MIRA™ is a miRNA-based endometrial receptivity test that determines the optimal time for embryo transfer.
Our microRNA (miRNA) biomarkers allow for a less invasive biopsy procedure and more reliable results, increasing the chances of a successful IVF treatment cycle.